NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 17, 2026 — Quantum BioPharma (NASDAQ: QNTM) receives Buy rating and $8 price target from Rodman & Renshaw, highlighting its neurodegenerative and metabolic disorder pipeline.
September 17, 2026 — VolitionRx launches DETECSEPS project with €6.3M French funding to detect sepsis early using Nu.Q NETs biomarker and IDS France analyzer.
September 17, 2026 — Earth Science Tech (OTCQB: ETST) uplists to OTCQB Venture Market, enhancing credibility and investor visibility. Learn about its integrated healthcare strategy.
September 17, 2026 — VERAXA Biotech names Raju Willener as CFO, bringing 30+ years of capital markets expertise to advance its BiTAC oncology pipeline and BiTAC-ADC platform.
September 17, 2026 — AHA statement: Women's kidney health overlooked, delaying diagnosis and treatment. Learn about unique risks and calls for precision care in CKD.
September 17, 2026 — Employers Think Pink urges businesses to give paid time off for mammograms. Launched by Davis, Saperstein & Salomon, P.C., it aims to save lives through early detection.
September 17, 2026 — Creative Biolabs launches a comprehensive service suite for targeted bispecific ADC development, covering biparatopic design, HER2-targeted ADCs, and preclinical evaluation.
September 17, 2026 — XpertDox partners with Kai Shin Clinic to bring AI-powered autonomous medical coding to behavioral health, improving accuracy, compliance, and revenue cycle efficiency.
September 17, 2026 — Fort Worth dentist offers tips to reduce dental implant costs without sacrificing quality. Learn how to compare plans, check insurance, and find affordable financing.
September 17, 2026 — Kidder Dental now offers dental crowns, bridges, implants, TMJ therapy, and sedation dentistry in Baton Rouge, LA, providing comprehensive restorative care under one roof.
September 16, 2026 — VERAXA Biotech advances its BiTAC platform for bispecific ADCs and T-cell engagers, with lead TCE entering development and VXA-222 progressing beyond discovery.
September 16, 2026 — Earth Science Tech (OTC: ETST) reports Q1 2027 revenue up 3% to $9.0M, net income up 57% to $715,697, operating cash flow doubles to $707,131, total assets up 33.3% to $10.4M.
September 16, 2026 — Dr. Rebeca Zechmann of River Landing Dentistry joins the Group Practice Accelerator Podcast to discuss clinical coaching, practice growth, and comprehensive dental care in Charleston.
September 16, 2026 — VERAXA Biotech advances BiTAC platform for antibody-based cancer therapies, targeting ADCs and T-cell engagers to enhance selectivity and reduce toxicity in solid tumors.
September 16, 2026 — New AHA statement: Cardiovascular disease surpasses cancer as leading cause of death among Hispanic adults. Learn about disparities, risk factors, and action plan.
September 16, 2026 — Mount Sinai study reveals pancreatic cancer evades immune system via blood clotting. Targeting this may boost immunotherapy. Read more on TechMediaWire.
September 16, 2026 — SS Innovations reports 238 SSi Mantra installations and 14,103 procedures, with global expansion and FDA/EU regulatory progress.
September 16, 2026 — Oragenics to present ONP-002, a first-in-class intranasal neurosteroid for concussion, at IPAC-RS 2026. Phase IIa trial enrolling; IND submission expected Q4 2026.
September 16, 2026 — Kristen Walker, Clinical Director at Counseling and Wellness Center of Pittsburgh, featured in Pittsburgh City Paper discussing AI's role in therapy and psychiatry.
September 16, 2026 — GeoVax develops a Bundibugyo virus vaccine construct using its rapid-cloning MVA technology, building on filovirus experience to address an ongoing outbreak.